These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21444902)

  • 1. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy.
    Androdias G; Maillet D; Marignier R; Pinède L; Confavreux C; Broussolle C; Vukusic S; Sève P
    Neurology; 2011 Mar; 76(13):1168-72. PubMed ID: 21444902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil.
    Bitoun S; Bouvry D; Borie R; Mahevas M; Sacre K; Haroche J; Psimaras D; Pottier C; Mathian A; Hie M; Boutin DL; Papo T; Godeau B; Valeyre D; Nunes H; Amoura Z; Cohen Aubart F
    Neurology; 2016 Dec; 87(24):2517-2521. PubMed ID: 27856779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil as a steroid-sparing agent in sarcoid-associated renal disease.
    Zaidi AA; DeVita MV; Michelis MF; Rosenstock JL
    Clin Nephrol; 2015 Jan; 83(1):41-4. PubMed ID: 24075023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study.
    Brill AK; Ott SR; Geiser T
    Respiration; 2013; 86(5):376-83. PubMed ID: 23295253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis.
    Bhat P; Cervantes-Castañeda RA; Doctor PP; Anzaar F; Foster CS
    Ocul Immunol Inflamm; 2009; 17(3):185-90. PubMed ID: 19585361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil as an alternative treatment in sarcoidosis.
    Papiris S; Stagaki E; Papadaki G; Kolilekas L; Korbila I; Apollonatou V; Kallieri M; Gialafos H; Chatziioannou S; Papaioannou AI; Manali ED
    Pulm Pharmacol Ther; 2019 Oct; 58():101840. PubMed ID: 31518648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of mycophenolate mofetil in sarcoidosis.
    Hamzeh N; Voelker A; Forssén A; Gottschall EB; Rose C; Mroz P; Maier LA
    Respir Med; 2014 Nov; 108(11):1663-9. PubMed ID: 25301291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
    Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
    Siepmann K; Huber M; Stübiger N; Deuter C; Zierhut M
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil in the treatment of uveitis in children.
    Doycheva D; Deuter C; Stuebiger N; Biester S; Zierhut M
    Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of primary angiitis of the central nervous system in childhood with mycophenolate mofetil.
    Sen ES; Leone V; Abinun M; Forsyth R; Ramesh V; Friswell M; O'Callaghan F; Ramanan AV
    Rheumatology (Oxford); 2010 Apr; 49(4):806-11. PubMed ID: 20100791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis.
    Kouba DJ; Mimouni D; Rencic A; Nousari HC
    Br J Dermatol; 2003 Jan; 148(1):147-8. PubMed ID: 12534610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil as an immunosuppressive agent in refractory inflammatory eye disease.
    Choudhary A; Harding SP; Bucknall RC; Pearce IA
    J Ocul Pharmacol Ther; 2006 Jun; 22(3):168-75. PubMed ID: 16808677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil.
    Moudgil A; Przygodzki RM; Kher KK
    Pediatr Nephrol; 2006 Feb; 21(2):281-5. PubMed ID: 16362392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil.
    Moravan M; Segal BM
    Neurology; 2009 Jan; 72(4):337-40. PubMed ID: 19171830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurosarcoidosis treated with mycophenolate mofetil: two cases].
    Chaussenot A; Bourg V; Chanalet S; Fornari JM; Lebrun C
    Rev Neurol (Paris); 2007 Apr; 163(4):471-5. PubMed ID: 17452949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H
    Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.